These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
602 related articles for article (PubMed ID: 16613697)
1. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children]. Tang SQ; Huang DS; Wang JW; Feng C; Yang G Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):93-6. PubMed ID: 16613697 [TBL] [Abstract][Full Text] [Related]
2. [Therapeutic effects of high dose chemotherapy combined with autologous peripheral blood stem cell transplantation for neural ectodermal solid tumor originated from neural crest in children]. Zhang WL; Zhang Y; Huang DS; Wang YZ; Zhu X; Hong L; Li P; Zhang PW; Zhou Y Zhongguo Dang Dai Er Ke Za Zhi; 2010 Apr; 12(4):244-7. PubMed ID: 20416211 [TBL] [Abstract][Full Text] [Related]
3. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update. George RE; Li S; Medeiros-Nancarrow C; Neuberg D; Marcus K; Shamberger RC; Pulsipher M; Grupp SA; Diller L J Clin Oncol; 2006 Jun; 24(18):2891-6. PubMed ID: 16782928 [TBL] [Abstract][Full Text] [Related]
4. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience. Avramova B; Jordanova M; Michailov G; Konstantinov D; Christosova I; Bobev D J BUON; 2006; 11(4):433-8. PubMed ID: 17309174 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of efficacy of treatment for 30 children with neuroblastoma]. Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065 [TBL] [Abstract][Full Text] [Related]
6. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation. Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH; Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634 [TBL] [Abstract][Full Text] [Related]
7. A novel intensive induction therapy for high-risk neuroblastoma utilizing sequential peripheral blood stem cell collection and infusion as hematopoietic support. Pradhan KR; Johnson CS; Vik TA; Sender LS; Kreissman SG Pediatr Blood Cancer; 2006 Jun; 46(7):793-802. PubMed ID: 16206215 [TBL] [Abstract][Full Text] [Related]
8. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Schetelig J; Fetscher S; Reichle A; Berdel WE; Beguin Y; Brunet S; Caballero D; Majolino I; Hagberg H; Johnsen HE; Kimby E; Montserrat E; Stewart D; Copplestone A; Rösler W; Pavel J; Kingreen D; Siegert W Haematologica; 2003 Nov; 88(11):1272-8. PubMed ID: 14607756 [TBL] [Abstract][Full Text] [Related]
9. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study]. Shi Y; Pan F; Han X Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500 [TBL] [Abstract][Full Text] [Related]
10. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma. Bradfield SM; Douglas JG; Hawkins DS; Sanders JE; Park JR Cancer; 2004 Mar; 100(6):1268-75. PubMed ID: 15022296 [TBL] [Abstract][Full Text] [Related]
11. [High-dose chemoradiotherapy with bone marrow transplantation as a consolidation treatment of neuroblastoma. Results in 49 unselected patients with stage IV cancer and older than 1 year. Report of the LMCE neuroblastoma group]. Kremens B; Philip T; Bernard JL; Zucker JM Klin Padiatr; 1987; 199(3):218-23. PubMed ID: 3306132 [TBL] [Abstract][Full Text] [Related]
12. Neuroblastoma. Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111 [TBL] [Abstract][Full Text] [Related]
13. Application of autologous peripheral blood stem cell transplantation in children with malignant tumor. Tang S; Huang D; Wang J; Wei X; Ran C; Peng Y; Lu S; Zhang J Chin Med J (Engl); 2001 Oct; 114(10):1098-101. PubMed ID: 11677775 [TBL] [Abstract][Full Text] [Related]
14. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant. von Allmen D; Grupp S; Diller L; Marcus K; Ecklund K; Meyer J; Shamberger RC J Pediatr Surg; 2005 Jun; 40(6):936-41; discussion 941. PubMed ID: 15991174 [TBL] [Abstract][Full Text] [Related]
15. High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk neuroblastoma patients. Molina B; Alonso L; Gonzalez-Vicent M; Andion M; Hernandez C; Lassaletta A; Cormenzana M; Lopez-Ibor B; Villa M; Molina J; Diaz MA Pediatr Hematol Oncol; 2011 Mar; 28(2):115-23. PubMed ID: 21299340 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes in patients with stage IV neuroblastoma. Escobar MA; Grosfeld JL; Powell RL; West KW; Scherer LR; Fallon RJ; Rescorla FJ J Pediatr Surg; 2006 Feb; 41(2):377-81. PubMed ID: 16481255 [TBL] [Abstract][Full Text] [Related]
17. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission. Papajik T; Raida L; Faber E; Vondrakova J; Prochazka V; Kubova Z; Skoumalova I; Jarosova M; M LK; Paucek B; Myslivecek M; Neoral C; Oral I; Jarkovsky J; Dusek L; Indrak K Neoplasma; 2008; 55(3):215-21. PubMed ID: 18348654 [TBL] [Abstract][Full Text] [Related]
18. [Metastatic neuroblastoma: consolidation treatment with 2 courses of high-dose chemotherapy followed by a bone marrow autograft]. Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A Bull Cancer; 1988; 75(1):119-23. PubMed ID: 3282574 [TBL] [Abstract][Full Text] [Related]
19. Peripheral blood stem cell autografts for the treatment of children over 1 year old with stage IV neuroblastoma: a long-term follow-up. Eguchi H; Takaue Y; Kawano Y; Watanabe A; Watanabe T; Kikuta A; Koizumi S; Matsumura T; Sawada A; Horikoshi Y; Sekine Y; Koyama T; Shimokawa T; Shimizu K; Kawasaki K; Mugishima H; Takayama J; Ohira M; Ogawa M Bone Marrow Transplant; 1998 May; 21(10):1011-4. PubMed ID: 9632274 [TBL] [Abstract][Full Text] [Related]
20. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study. Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]